38 results about "Treatment intervention" patented technology

An apparatus and method for stimulating the neurochemistry of the brain including enzymes, nucleosides, nucleotides, neuropeptides, neurotransmitters, amino acids, brain glucose, steroids, and hormones, and more specifically, an apparatus and method for enhancing overall brain function, including cognitive abilities and intelligence quota (IQ). Other treatment interventions the apparatus and method can positively affect include neurological, physiological, and psychological disorders and diseases. The inventive method utilizes a specially designed goggle which contains two round eye pieces to which are attached the light assemblies. These light assemblies are comprised of 1-20 white full spectrum lights which are directed toward both eyes, within a two inch radius of the retina to avoid overstimulation. The goggle has an expandable nose piece with a mechanism to allow the eye pieces to swing outward and adjust over the eye of any individual, in accordance with the specified retinal placement. The inset lights flash or flicker utilizing intermittent “fuzzy” light, and encompass frequencies ranging from 1-1200 Hz (cycles per second), specifically excluding the range between 55-65 Hz to prevent any form of seizure. The light stimulus is accompanied by unmatched, intermittent sound stimulation, called “fuzzy” sound. The sound is audible through the use of any type headphone. The method is in the form of computerized programs, and includes a variety of formulas translated as “sessions” to be downloaded into any existing light / sound device or apparatus. These formulas are in the form of a variety of sessions, lasting no more than 40 minutes each, to address and or treat a variety of symptoms, disorders, and diseases. The sessions control the light goggle apparatus and sound. Neither the “fuzzy” light nor the “fuzzy” sound are synchronized.

An interactive computer assisted method compiles comprehensive health care information on patients in a central repository, assesses and analyzes this information, and identifies high utilizers of health care services using a computer and a user associated therewith. The method includes the steps of creating a central repository of various databases containing patient information, including demographic information and behavior, and optionally the results of a core survey of health status questions. The invention optionally involves the step of determining the appropriate core questions and the criteria to determine whether and when to ask certain questions of particular patients based on their response to prior questions. The invention accurately predicts risk of a medical condition or progression of a medical condition utilizing an interactive administration of a set of core survey questions combined with diagnostic data and places patients efficiently, reliably, and accurately into the appropriate treatment intervention programs. The invention eliminates redundant, repetitive surveying of patients with multiple medical conditions.

The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's or non-Alzheimer's dementia or normal. The biomarkers can be detected by SELDI mass spectrometry. In addition, the invention provides appropriate treatment interventions and methods for measuring response to treatment. Certain biomarkers of the invention may also be suitable for employment as radio-labeled ligands in non-invasive imaging techniques such as Positron Emission Tomography (PET).

The invention discloses an application of a group of gastric cancer genes. In the invention, based on a group of 53 prognosis related genes in gastric cancer and the detection results of the expression levels thereof in clinical samples, the score is calculated and predicted to evaluate clinical prognosis of gastric cancer as well as related application thereof. The system can help the gastric cancer patients in treatment selection and can predict the reaction to treatment intervention so as to judge whether the patients profit from chemical and targeted therapy, excessive medication is avoided, the medical cost is reduced, and finally, an aim of accurate or individualized medicine is achieved. According to the system and different detection technology platforms, corresponding 53 gene expression measurement kits are designed and developed.

The invention provides a visual cortex positioning method with transcranial magnetic stimulation. The stimulation intensity correction and the stimulation target positioning are based on the special sensory perception characteristic of the visual cortex, the double information of the visual cortex function and the anatomical structure of a person to be stimulated is obtained, and the positioning is accurate. The invention provides a keyboard connected to an rTMS parameter console, keys replace oral input so as to reduce the possibility of head movement, further increase the positioning accuracy and improve the efficiency of next treatment intervention. According to the invention, starting from the mean intensity of the stimulation threshold PT, the intensity is increased by 2% step by stepalong with retest reliability test method, three areas of information of brain appearance, brain anatomical structure and brain functional area positioning of the person to be stimulated is fully integrated, the positioning accuracy is ensured, and the method is superior to a TMS positioning method which is carried out by simply utilizing the brain information in one aspect in the prior art.

The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders, and also for the treatment of mast cell-related processes and disorders, ischemic disorders and injuries, including ischemic renal disorders and injuries. For example, genes which are differentially expressed within and among T helper (TH) cells and TH cell subpopulations, which include, but are not limited to TH0, TH1 and TH2 cell subpopulations are identified. Genes are also identified via the ability of their gene products to interact with gene products involved in the differentiation, maintenance and effector function of such TH cells and TH cell subpopulations. The genes identified can be used diagnostically or as targets for therapeutic intervention. In this regard, the present invention provides methods for the identification and therapeutic use of compounds as treatments of immune disorders, especially TH cell subpopulation-related disorders. Additionally, methods are provided for the diagnostic evaluation and prognosis of TH cell subpopulation-related disorders, for the identification of subjects exhibiting a predisposition to such conditions, for monitoring patients undergoing clinical evaluation for the treatment of such disorders, and for monitoring the efficacy of compounds used in clinical trials. Methods are also provided for the treatment of symptoms associated with mast cell-related processes or disorders and ischemic disorders and injuries using the genes, gene products and antibodies of the invention.

The invention discloses an antibody IgG against Staphylococcus aureus serine-rich repeat protein SraP and application. The antibody can specifically bind to an L-Lectin motif of the serine-rich repeatprotein, can bind to Staphylococcus aureus surface anchored protein SraP to reduce cell adhesion and invasion of Staphylococcus aureus and the number of bacteria in blood of mice, and can be used asan action target for an anti-Staphylococcus aureus infection antibody in treatment intervention.

The invention belongs to the technical field of computers, and in particular relates to a medical intelligent triage method and system. The medical intelligent triage method includes: extracting disease-related symptoms and signs from patient information as candidate factor information; according to the candidate factor information, obtaining various symptoms-related diseases and treatment measures from medical literature as identification knowledge information ;Match the identification knowledge information with the candidate factor information; repeat the above steps until it is determined that the department or patient information of the disease has been extracted and matched, and return the triage result. The method and system discover relevant knowledge and rules from medical literature or other medical data by analyzing the content of interactions with patients to form medical evidence for identifying knowledge information, and then analyze the patient's illness and give relevant suggestions. In order to achieve the purpose of matching possible diseases and their affiliated specialties according to the main symptoms and signs of patients, and recommending effective medical departments or medical treatment routes.

The invention discloses a hand and foot meridian regulating machine. The hand and foot meridian regulating machine comprises a housing, wherein the housing adopts a transparent cylinder structure, anend port is formed in one end of the housing and protrudes from the outside wall of the housing, and a plurality of functional module mounting holes are formed in the outer side of the housing. A cavity is subjected to operations of pumping, inflating and the like, pressure changes on the surface of the skin of a human body, contained in the cavity, can be realized, so that the muscle, meridians,tendons and bones in the position can be comprehensively relaxed or compressed, and external treatment intervention useful for meridian dredging for the human body can be generated. The hand and footmeridian regulating machine does not omit tiny joint meridians for hands and feet, the transparent housing can enable the limbs to be conveniently observed, and more visual convenient and humanized operations can be realized. An emergency air escape can prevent accidents.

The embodiments of the present disclosure disclose an information generation method and device. First, at least one treatment intervention technique text of a target user is sorted in chronological order to obtain a treatment intervention technique text sequence L[C 1 , C 2 , C 3 ...C n ]; the text sequence L[C 1 , C 2 , C 3 ...C n ] input to the pre-trained recurrent neural network for prediction, the last element C in the output sequence n The Next Therapeutic Intervention Technique Text C n+1 ; and then input each obtained sequence of treatment intervention technical texts into the pre-trained recurrent neural network for prediction, and after cyclic execution of preset times m times, a sequence L[C 1 , C 2 , C 3 ...C n , C n+1 ,...C n+m ], using the historical treatment intervention technical text based on the target user can quickly predict the treatment intervention technical text in the next stage.

One or more embodiments of the invention provide a clinical decision-making method and device, and the clinical decision-making method comprises the steps: obtaining a sample data set of a plurality of observed objects for a preset disease, and the sample data set comprises the data features of the observed objects; clustering based on data features in the sample data set to obtain a plurality ofclustering groups; obtaining an end point event of the observed object in each clustering group; determining a target clustering group from the plurality of clustering groups according to the physiological indexes of the observed object in the end point event; acquiring data characteristics of the patient; according to the correlation between the data characteristics of the patient and the data characteristics of the observed objects in the target clustering group, carrying out clinical decision making on the patient. According to the method, clinical decision making can be carried out on thepatient by referring to treatment measures of the observed objects in the target clustering group; therefore, the targeted, practical and effective treatment measures can be provided for patients.

The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders, and also for the treatment of mast cell-related processes and disorders, ischemic disorders and injuries, including ischemic renal disorders and injuries. For example, genes which are differentially expressed within and among T helper (TH) cells and TH cell subpopulations, which include, but are not limited to TH0, TH1 and TH2 cell subpopulations are identified. Genes are also identified via the ability of their gene products to interact with gene products involved in the differentiation, maintenance and effector function of such TH cells and TH cell subpopulations. The genes identified can be used diagnostically or as targets for therapeutic intervention. In this regard, the present invention provides methods for the identification and therapeutic use of compounds as treatments of immune disorders, especially TH cell subpopulation-related disorders. Additionally, methods are provided for the diagnostic evaluation and prognosis of TH cell subpopulation-related disorders, for the identification of subjects exhibiting a predisposition to such conditions, for monitoring patients undergoing clinical evaluation for the treatment of such disorders, and for monitoring the efficacy of compounds used in clinical trials. Methods are also provided for the treatment of symptoms associated with mast cell-related processes or disorders and ischemic disorders and injuries using the genes, gene products and antibodies of the invention.

The invention relates to the use of novel biomarkers and biomarker combinations having utility in the early determination of an individual's critical and / or life threatening response to illness and / or in predicting outcome of said illness. The measurement of expression levels of the products of the biomarkers and combinations of biomarkers of the invention have utility in making the determination of an individual's critical and / or life threatening response to illness. In some embodiments, the biomarker and biomarker combinations are agnostic and are independent of the pre-identification and / or determination of the cause or nature of the illness. In some embodiments, the biomarkers and biomarker combinations can be utilized to select treatment and / or monitor the effectiveness of treatment interventions for an individual who has a critical illness.

The invention discloses a tumour treatment intervention apparatus including a needle tubing and a support seat, the needle tubing is plugged into a circular hole left in the middle of the support seat, the pipe walls at the two sides of the needle tubing are provided with tooth bars, the inner cavities at the two sides of the support seat are provided with grooves, the walls of the grooves are connected with ratchet wheels and pawls through shafts, the pawls are arranged at the upper sides of the ratchet wheels, the pawls are engaged with one sides of the ratchet wheels, and the other sides of the ratchet wheels are engaged with the tooth bars, and the inner end parts of adjusting rods are hinged to the upper ends of the pawls. The intervention apparatus controls the distance of the syringe needle inserting into the human body through the ratchet wheel and tooth bar structure, so that the distance from the syringe needle to the pathological part is controlled in high precision. By means of the support leg structure, the use stability of the intervention apparatus is improved, and by means of the support leg telescoping structure, the intervention apparatus can make adjustment according to different body parts, so that the use scope of the apparatus is enlarged. In addition, the intervention apparatus has the advantages of simple use, high precision, and low cost.